🧪
hypothesis

G4C2 RNA Decoy Therapeutics

Hypothesis

G4C2 RNA Decoy Therapeutics

Engineered decoy RNAs containing modified G4C2 repeats could sequester pathological RNA species and prevent their interference with normal RNP condensate formation.
🧬 C9orf72🎯 Composite 0%💱 $0.51▲1.3%proposed
neurodegeneration
EvidenceModerate (50%)📖 0 cit🗣 1 debates 1 support 0 oppose
✓ All Quality Gates Passed
Mechanistic 0.60 (15%) Evidence 0.55 (15%) Novelty 0.60 (12%) Feasibility 0.00 (12%) Impact 0.00 (12%) Druggability 0.00 (10%) Safety 0.00 (8%) Competition 0.00 (6%) Data Avail. 0.00 (5%) Reproducible 0.00 (5%) KG Connect 0.44 (8%) 0.000 composite
☰ Compare⚔️ Duel⚛️ Collide
📄 Export LaTeX
arXiv PreprintNeurIPSNature MethodsPLOS ONE
📖 Export BibTeXinteract with this hypothesis
Composite0%

🧪 Overview

Engineered decoy RNAs containing modified G4C2 repeats could sequester pathological RNA species and prevent their interference with normal RNP condensate formation.

Debate provenance: derived from debate `sess_SDA-2026-04-11-sda-2026-04-01-gap-006` on question: TDP-43 phase separation therapeutics for ALS-FTD. Consensus signal: domain_expert, skeptic, synthesizer, theorist discussed the mechanism terms Decoy, G4C2, RNA, RNP, Therapeutics. Novelty signal: skeptic-discussed-with-qualified-concession.

🧬 Mechanism

🔗 Mechanism from KG for C9orf72

Auto-built from this analysis's top knowledge-graph edges.

graph TD
    C9orf72["C9orf72"] -->|produces pathologi| DPR_proteins["DPR_proteins"]
    C9orf72_1["C9orf72"] -->|risk factor for| ALS_FTD["ALS/FTD"]
    C9orf72_DPR_neutralizing_["C9orf72 DPR neutralizing agents"] -->|prevents| TDP_43_phase_separation_d["TDP-43 phase separation disruption"]
    C9ORF72["C9ORF72"] -->|increases risk| Familial_ALS["Familial ALS"]
    C9ORF72_2["C9ORF72"] -->|co discussed| HSP70["HSP70"]
    C9ORF72_3["C9ORF72"] -->|co discussed| TAU["TAU"]
    style C9orf72 fill:#ce93d8,stroke:#333,color:#000
    style DPR_proteins fill:#4fc3f7,stroke:#333,color:#000
    style C9orf72_1 fill:#ce93d8,stroke:#333,color:#000
    style ALS_FTD fill:#ef5350,stroke:#333,color:#000
    style C9orf72_DPR_neutralizing_ fill:#4fc3f7,stroke:#333,color:#000
    style TDP_43_phase_separation_d fill:#4fc3f7,stroke:#333,color:#000
    style C9ORF72 fill:#ce93d8,stroke:#333,color:#000
    style Familial_ALS fill:#ef5350,stroke:#333,color:#000
    style C9ORF72_2 fill:#ce93d8,stroke:#333,color:#000
    style HSP70 fill:#ce93d8,stroke:#333,color:#000
    style C9ORF72_3 fill:#ce93d8,stroke:#333,color:#000
    style TAU fill:#ce93d8,stroke:#333,color:#000

⚖️ Evidence

📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — C9ORF72

No curated PDB or AlphaFold mapping for C9ORF72 yet. Search RCSB →

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for C9orf72 →

No DepMap CRISPR Chronos data found for C9orf72.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0002
Events (7d)
1
Price History
▲1.3%

💾 Resource Usage

LLM Tokens
51,518
$0.3091
Total Cost
$0.3091
View on SciDEX ↗